Coricidin HBP Day & Night Multi-Symptom Cold Interactions
There are 538 drugs known to interact with Coricidin HBP Day & Night Multi-Symptom Cold (acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin), along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 93 are major, 428 are moderate, and 17 are minor.
- View all 538 medications that may interact with Coricidin HBP Day & Night Multi-Symptom Cold
- View Coricidin HBP Day & Night Multi-Symptom Cold alcohol/food interactions (2)
- View Coricidin HBP Day & Night Multi-Symptom Cold disease interactions (7)
Most frequently checked interactions
View interaction reports for Coricidin HBP Day & Night Multi-Symptom Cold (acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin) and the medicines listed below.
- acetaminophen
- albuterol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- Benadryl (diphenhydramine)
- benzonatate
- cephalexin
- cetirizine
- Claritin (loratadine)
- doxycycline
- famotidine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- hydrochlorothiazide
- hydrocodone
- ibuprofen
- lisinopril
- loratadine
- losartan
- metoprolol
- Mucinex (guaifenesin)
- omeprazole
- prednisone
- rosuvastatin
- tamsulosin
- Tylenol (acetaminophen)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zyrtec (cetirizine)
Coricidin HBP Day & Night Multi-Symptom Cold alcohol/food interactions
There are 2 alcohol/food interactions with Coricidin HBP Day & Night Multi-Symptom Cold (acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin).
Coricidin HBP Day & Night Multi-Symptom Cold disease interactions
There are 7 disease interactions with Coricidin HBP Day & Night Multi-Symptom Cold (acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin) which include:
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.